A PSA result can be difficult to interpret, when a number is unexpectedly high. Prostate-specific antigen (PSA) is a protein made by prostate cells and measured in blood. A raised level can occur without cancer. A low reading does not exclude cancer. People looking for a top urologist in mumbai or the best urologist in mumbai want to understand age-related PSA and screening. The answer depends on personal risk, past results, overall health, and discussion with a clinician.
PSA enters the bloodstream from both healthy and abnormal prostate tissue. Laboratories report the result in nanograms per millilitre (ng/mL). Testing involves taking a blood sample.
PSA may be used to discuss screening in people without symptoms, investigate certain prostate concerns, or monitor patients after prostate cancer treatment. Interpretation depends on the reason for testing.
PSA often rises as the prostate enlarges with age. Common age-specific upper reference values include:
40–49 years: 2.5 ng/mL
50–59 years: 3.5 ng/mL
60–69 years: 4.5 ng/mL
70–79 years: 6.5 ng/mL
These figures are not diagnostic boundaries. Guidelines and laboratories may use different thresholds. Cancer can occur below these values, and benign conditions can produce higher readings. A clinician also considers how the result has changed over time and whether there are other risk factors.
Several conditions and circumstances affect PSA:
Benign prostate enlargement: Common with increasing age and not itself cancer.
Prostatitis or urinary infection: Inflammation can temporarily increase the reading.
Urinary retention: Difficulty emptying the bladder may raise PSA.
Recent activity or procedures: Ejaculation, cycling, and some prostate procedures can affect measurements.
Certain medicines: Finasteride and dutasteride can lower PSA and change how results are interpreted.
Disclose infections, procedures, medicines, and relevant activities. Do not stop medication without medical advice.
Screening is not automatically necessary every year. Different medical organisations recommend slightly different starting ages.
The American Cancer Society recommends discussing screening from age 50 for men at average risk who are expected to live at least another ten years. It advises earlier conversations at age 45 for certain higher-risk men and age 40 for men with multiple close relatives diagnosed young.
The American Urological Association suggests that average-risk adults may consider a baseline PSA test between ages 45 and 50, with earlier consideration for increased-risk individuals. Family history, inherited genetic variants, and personal circumstances can change the discussion.
A top urologist in mumbai can explain which guidance applies to your circumstances, including testing intervals.
For example, two men of the same age may receive different advice because their previous results, family histories, and preferences are not the same.
PSA screening can help detect some important prostate cancers before symptoms appear. Research shows that screening can reduce deaths from prostate cancer, although the benefit is balanced against possible harms.
An elevated result may lead to anxiety, repeat blood tests, imaging, or biopsy even when cancer is absent. Screening can also find slow-growing cancers that might never have affected someone’s health. Treatment may cause urinary or sexual side effects. Understanding these trade-offs is an important part of choosing whether to screen.
One result rarely tells the whole story. A doctor may recommend repeating the test, particularly when a temporary increase is possible. Further assessment might include a clinical examination, risk assessment tools, prostate MRI, or biopsy.
MRI helps locate suspicious areas, while biopsy can confirm whether cancer is present. Not everyone with a raised PSA needs a biopsy. The best urologist in mumbai for your situation is a clinician who explains why each investigation is being considered, including its benefits and limitations.
Bring previous PSA reports, your medication list, and any relevant family history. Mention urinary symptoms and recent infections. Ask what your current result means, whether repeating it is appropriate, and what would happen if it remains elevated. Visible blood in urine or new persistent urinary problems should be assessed separately from routine screening decisions.
An often-cited upper reference value for ages 60–69 is 4.5 ng/mL. It is not a universal cutoff, and individual risk still matters.
No. Enlargement, inflammation, and other conditions can raise PSA. Additional evaluation may be appropriate, but PSA alone cannot diagnose cancer.
No. Screening frequency depends on age, baseline PSA, risk factors, health, and personal preference after discussion with a clinician.
Consider an assessment for persistently raised PSA, concerning symptoms, significant family history, or questions about screening decisions.
Look for clear explanations, experience evaluating prostate concerns, shared decision-making, and discussion of testing benefits and potential harms.
No. Some cancers occur despite relatively low PSA. Results should be considered alongside symptoms, family history, and other findings.
Dr. Mangesh Patil is a renowned Urologist, and is trained in Endourology and Robotic Surgery , with professional experience of more than 10 years .
© 2024 – Urocare Clinic. All Right Reserved | Maintained By Rebecca Digital